Background illustration for clinical trials search

Paid Clinical Trials Akron

Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

for
Neoplasms, Lung
Location: Canton OH, Wilson NC, Los Angeles CA
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07602855

Phase 1, Phase 2, Recruiting

A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)

for
Gastrointestinal Stromal Neoplasms
Location: Canton OH, Bethesda MD, Knoxville TN, Durham NC,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07585266

Phase 3, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

for
Neoplasms, Colorectal, Neoplasms
Location: Canton OH, Detroit MI, Hamilton, Nashville TN, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07213609

Phase 1, Phase 2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Canton OH, Pittsburgh PA, Columbus OH, Ann Arbor MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Canton OH, Farmington Hills MI, Orchard Park NY,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of BHV-1300 in Graves' Disease

for
Graves Disease
Location: Canton OH, Greenville NC, Memphis TN, Columbus GA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 65

Code: NCT06980649

Phase 1, Recruiting

A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments

for
Multiple Myeloma
Location: Canton OH, Grand Rapids MI, Chapel Hill NC, New York NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05714839

Phase 1, Phase 2, Recruiting

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

for
Neoplasms, Lung
Location: Canton OH, Toronto, East Syracuse NY, Hinsdale IL,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07099898

Phase 3, Recruiting

A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome

for
Myelodysplastic Syndromes
Location: Canton OH, New Haven CT, Toronto, Calgary, Houston TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06847867

Phase 2, Recruiting

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

for
Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
Location: Canton OH, Dublin OH, Sterling Heights MI, Lansing MI,
Sponsor: Alkermes, Inc.

Sex: All

Age: 18 - 70

Code: NCT06767683

Phase 2, Phase 3, Recruiting

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

for
Neoplasms, Head and Neck
Location: Canton OH, Pittsburgh PA, Hamilton, Fort Wayne IN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06256588

Phase 3, Recruiting

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

for
Hypogammaglobulinemia, Bacterial Infections,
Location: Canton OH, Bethesda MD, Morrisville NC, Wilson NC,
Sponsor: Grifols Therapeutics LLC

Sex: All

Age: 18+

Code: NCT05645107

Phase 3, Recruiting

A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Canton OH, Lexington KY, Plantation FL
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Sex: All

Age: 18 - 70+

Code: NCT06592638

Phase 1, Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Medina OH, Canton OH, Mayfield Heights OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

Prescriptive Mobilization Versus a Pragmatic Mobilization

for
Mechanical Low Back Pain
Location: North Canton OH
Sponsor: Walsh University

Sex: All

Age: 18+

Code: NCT01940744

Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndromes
Location: Canton OH, Cleveland OH, London, Toronto, Columbia MD,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06499285

Phase 3, Recruiting

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

for
Higher-risk Myelodysplastic Syndromes
Location: Canton OH, Columbus OH, Bethesda MD, Columbia MD,
Sponsor: Akeso

Sex: All

Age: 18+

Code: NCT06196203

Phase 2, Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Canton OH, Columbus OH, Buffalo NY, Newark DE,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase 1, Recruiting

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

for
Solid Tumor, Adult
Location: Canton OH
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT06056323

Phase 1, Phase 2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Canton OH, Independence OH, Cleveland OH,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting